Title:
APPLICATION OF LEVALBUTEROL FORMULATION IN TREATMENT OF SKIN AND MUCOUS MEMBRANE TRAUMATIC ULCERS
Document Type and Number:
WIPO Patent Application WO/2016/078609
Kind Code:
A1
Abstract:
Provided in the present invention is an (R)-albuterol pharmaceutically acceptable salt or pharmaceutical formulation thereof, and the application thereof in the preparation of drugs for the treatment of diseases such as skin ulcers, lesions, purulence, or delayed healing caused by trauma, pressure sores, tumours, diabetes, or coinfection. The pharmaceutical formulation contains the levalbuterol pharmaceutically acceptable salt, or the levalbuterol pharmaceutically acceptable salt and hormones, antibiotics, or anti-inflammatory drugs.
More Like This:
Inventors:
XU LING (CN)
TAN YIZHI (CN)
TAN EVINA (CN)
TAN YIZHI (CN)
TAN EVINA (CN)
Application Number:
PCT/CN2015/095101
Publication Date:
May 26, 2016
Filing Date:
November 20, 2015
Export Citation:
Assignee:
SUZHOU JUNNING R & D CT FOR INNOVATIVE DRUGS CO LTD (CN)
International Classes:
A61K31/137; A61P17/02
Foreign References:
CN104606177A | 2015-05-13 | |||
CN101378790A | 2009-03-04 |
Attorney, Agent or Firm:
SUNSHINE INTELLECTUAL PROPERTY INTERNATIONAL CO., LTD. (CN)
北京三聚阳光知识产权代理有限公司 (CN)
北京三聚阳光知识产权代理有限公司 (CN)
Download PDF: